-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Landos Biopharma, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2021 to Q1 2024.
- Landos Biopharma, Inc. Return On Equity for the quarter ending March 31, 2024 was -73 %, a 8.91% decline year-over-year.
- Landos Biopharma, Inc. annual Return On Equity for 2023 was -54.9 %, a 31.2% increase from 2022.
- Landos Biopharma, Inc. annual Return On Equity for 2022 was -79.8 %, a 95.8% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)